PLSE financial statements
The full income statement, balance sheet, and cash-flow statement for Pulse Biosciences Inc Common Stock (DE) (PLSE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 350K | 0.00 | 0.00-100.0% | 700K-50.6% | 1.42M | |
| Cost of revenue | 539K | 0.00 | 0.00-100.0% | 11.9M+506.9% | 1.97M | |
| Research & development | 44.7M+38.3% | 32.3M+16.3% | 27.8M+33.4% | 20.8M-27.2% | 28.6M+8.3% | |
| Selling, general & administrative | 32.0M+33.9% | 23.9M+51.6% | 15.8M+13.1% | 14.0M-26.8% | 19.1M+17.3% | |
| General & administrative | — | 23.9M+51.6% | 15.8M+13.1% | 14.0M-26.8% | 19.1M+17.3% | |
| Amortization of intangibles | 665K-0.2% | 666K+0.2% | 665K+0.0% | 665K-0.2% | 666K+0.2% | |
| Operating income | -76.9M-36.8% | -56.3M-29.1% | -43.6M+24.9% | -58.1M+7.9% | -63.0M-26.1% | |
| Other non-operating income | -52.0K-101.9% | 2.67M+95.9% | 1.36M+404.5% | -448K+30.7% | -646K-666.7% | |
| Pre-tax income | 72.8M+35.8% | 53.6M+227.0% | -42.2M+27.9% | -58.5M+8.1% | -63.7M-27.7% | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net income | -72.8M-35.8% | -53.6M-26.9% | -42.2M+27.9% | -58.5M+8.1% | -63.7M-27.7% | |
| EPS (basic) | -$1.08-17.4% | -$0.92-8.2% | -$0.85+50.6% | -$1.72+24.6% | -$2.28-6.5% | |
| Weighted-avg shares (basic) | 67.4M+15.4% | 58.4M+17.4% | 49.7M+46.6% | 33.9M+21.4% | 28.0M+20.3% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 83.4M-30.2% | 119M+163.5% | 45.3M-27.1% | 62.1M+37.1% | 45.3M+102.9% | ||
| Cash & equivalents | 80.7M-31.6% | 118M+166.1% | 44.4M-27.4% | 61.1M+37.8% | 44.4M+256.0% | |
| Cash & short-term investments | — | — | — | — | 28.6M | |
| Accounts receivable | 274K | 0.00 | — | 0.00-100.0% | 61.0K | |
| Inventory | 136K | 0.00 | — | 0.00-100.0% | 5.82M | |
| Prepaid expenses | 2.28M+61.3% | 1.41M+46.5% | 963K-4.5% | 1.01M+4.7% | 963K-48.3% | |
| 94.5M-28.6% | 132M+123.9% | 59.2M-24.0% | 77.9M+31.7% | 59.2M+43.3% | ||
| Property, plant & equipment | 1.05M-9.4% | 1.16M-24.1% | 1.53M-22.1% | 1.96M-20.3% | 2.46M-0.6% | |
| Operating lease right-of-use | 6.01M-16.1% | 7.16M-1.3% | 7.26M-10.0% | 8.06M-8.2% | 8.79M-6.9% | |
| Goodwill | 2.79M+0.0% | 2.79M+0.0% | 2.79M+0.0% | 2.79M+0.0% | 2.79M+0.0% | |
| Intangible assets | 575K-52.9% | 1.22M-35.3% | 1.89M-26.1% | 2.55M-20.7% | 3.22M-17.2% | |
| Other non-current assets | 691K+2.1% | 677K+85.5% | 365K+0.0% | 365K+0.0% | 365K+0.0% | |
| 7.92M-21.2% | 10.1M+49.9% | 6.71M+12.2% | 5.98M-10.8% | 6.71M-11.6% | ||
| Accounts payable | 2.78M+66.0% | 1.67M-8.9% | 1.84M+16.7% | 1.57M-14.3% | 1.84M+6.9% | |
| Accrued liabilities | 3.58M-49.1% | 7.03M+84.2% | 3.81M+47.0% | 2.60M-40.9% | 4.39M-17.6% | |
| Deferred revenue | — | — | — | 0.00-100.0% | 16.0K | |
| Current lease liability | 1.57M+15.9% | 1.35M+28.1% | 1.06M+18.1% | 896K+15.8% | 774K+42.8% | |
| 13.9M-21.1% | 17.6M+19.0% | 14.8M-81.5% | 80.1M+441.6% | 14.8M-19.6% | ||
| Non-current lease liability | 5.96M-21.0% | 7.54M-6.7% | 8.09M-11.6% | 9.14M-8.9% | 10.0M-7.2% | |
| Operating lease liability (total) | 7.53M-15.4% | 8.90M-2.7% | 9.14M-8.9% | 10.0M-7.2% | 10.8M-4.8% | |
| 80.7M-29.8% | 115M+158.9% | 44.4M+2073.3% | -2.25M-106.3% | 35.7M+55.9% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 68.0K+3.0% | 66.0K+20.0% | 55.0K+48.6% | 37.0K-32.7% | 55.0K+120.0% | |
| Additional paid-in capital | 544M+7.6% | 505M+32.5% | 381M+30.4% | 292M-23.3% | 381M+95.1% | |
| Retained earnings | -463M-18.6% | -391M-15.9% | -337M-14.3% | -295M+12.5% | -337M-95.3% | |
| Accumulated other comprehensive income | — | 0.00 | 0.00 | 0.00 | 0.00+100.0% | |
| Total liabilities & equity | 94.5M-28.6% | 132M+123.9% | 59.2M-24.0% | 77.9M+31.7% | 59.2M+43.3% | |
| Common shares issued | 67.8M+2.9% | 65.9M+19.6% | 55.1M+48.1% | 37.2M-32.5% | 55.1M+115.8% | |
| Common shares outstanding | 67.8M+2.9% | 65.9M+19.6% | 55.1M+48.1% | 37.2M-32.5% | 55.1M+115.8% | |
| Shares outstanding (cover) | 68.0M+1.1% | 67.3M+21.8% | 55.2M+46.9% | 37.6M+26.1% | 29.8M+14.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -54.1M-48.9% | -36.3M-10.0% | -33.0M+29.7% | -47.0M+13.1% | -54.1M-53.0% | ||
| Depreciation & amortization | 1.07M-9.1% | 1.18M-2.4% | 1.21M-10.9% | 1.35M+18.2% | 1.15M+4.7% | |
| Intangible amortization | 665K-0.2% | 666K+0.2% | 665K+0.0% | 665K-0.2% | 666K+0.2% | |
| Share-based compensation | 21.5M+57.9% | 13.6M+89.2% | 7.18M+38.3% | 5.19M-64.4% | 14.6M+44.9% | |
| Deferred income taxes | — | — | 0.00 | 0.00 | 0.00 | |
| Change in receivables | 274K | 0.00 | 0.00+100.0% | -61.0K-200.0% | 61.0K | |
| Change in inventory | 136K | 0.00 | 0.00-100.0% | 2.65M-54.4% | 5.82M | |
| Change in payables | 1.13M+663.2% | -201K-176.4% | 263K+120.2% | -1.30M-212.4% | 1.16M+536.1% | |
| -335K-168.0% | -125K-3.3% | -121K+69.8% | -401K-105.3% | 7.56M-24.7% | ||
| Capital expenditure | 315K+152.0% | 125K+3.3% | 121K-69.8% | 401K-8.2% | 437K-0.9% | |
| Free cash flow | -54.4M-49.3% | -36.5M-10.0% | -33.2M+30.1% | -47.4M+13.1% | -54.5M-52.3% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales/maturities of investments | — | — | — | 0.00-100.0% | 8.00M-77.1% | |
| 17.2M-84.4% | 110M+572.1% | 16.4M-79.5% | 79.9M+27.5% | 62.7M+103.0% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.94M | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00-100.0% | 14.9M-73.8% | 56.7M+92.6% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -37.3M-150.6% | 73.7M+539.2% | -16.8M-151.6% | 32.5M+101.4% | 16.2M+190.3% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 933M-20.3% | 1.17B+74.0% | 673M+552.7% | 103M-76.6% | 441M-29.1% | |
| P/S | 2667.1× | — | — | 66.4×-78.7% | 311.3× | |
| P/B | 11.6×+13.5% | 10.2×-21.0% | 12.9×-22.5% | 16.7×+34.7% | 12.4×-54.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: PLSE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PLSE filings on SEC EDGAR → Not investment advice.
